Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-425-9 | CAS number: 95-50-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Specific investigations: other studies
Administrative data
- Endpoint:
- hepatotoxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: acceptable, well-documented publication report which meets basic scientific principles
Data source
Reference
- Reference Type:
- publication
- Title:
- The differential hepatotoxicity and cytochrome P450 responses of Fischer-344 rats to the three isomers of dichlorobenzene
- Author:
- Allis, J.W. et al.
- Year:
- 1 992
- Bibliographic source:
- J. Biochem. Toxicology 7, 257-264 (1992)
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The acute hepatotoxicity and response of hepatic cytochrome P450 to treatment of 1,2-dichlorobenzene was investigated. Therefore, F-344 rats (one animal per dose level) were gavaged with up to 25 different dosages of 1,2-dichlorobenzene. The onset of toxicity was estimated and the role of cytochrome P450 in the metabolism and toxicity was elucidated in rats 24h after treatment.
- GLP compliance:
- not specified
- Type of method:
- in vivo
Test material
- Reference substance name:
- 1,2-dichlorobenzene
- EC Number:
- 202-425-9
- EC Name:
- 1,2-dichlorobenzene
- Cas Number:
- 95-50-1
- Molecular formula:
- C6H4Cl2
- IUPAC Name:
- 1,2-dichlorobenzene
- Details on test material:
- - Analytical purity: 99%
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles RIver Laboratories, Raleigh, NC
- Age at study initiation: 60-days-old
- Weight at study initiation: results not reported
- Housing: individually
- Diet: Purina Rodent Lab Chow (Number 5001, Ralston Purina, Checkerboard Square, MO)
- Water (e.g. ad libitum): yes
- Acclimation period: 5-8 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +- 2
- Humidity (%): 55 +- 5
- Photoperiod (hrs dark / hrs light): 12h
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
VEHICLE
- Amount of vehicle (if gavage): 10mL/kg bw - Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 24h
- Frequency of treatment:
- once
- Post exposure period:
- none
Doses / concentrations
- Remarks:
- Doses / Concentrations:
up to 25 different dosages, up to 1.27mL/kg bw (about 1784mg/kg bw)
Basis:
other: nomimal dose
- No. of animals per sex per dose:
- one
- Control animals:
- yes, concurrent vehicle
Examinations
- Examinations:
- 24h after dosing, rats were anesthetized, weighed and exsanguinated. Blood was centrifuged and serum concentrations of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase were determined by commercial assays. After weighing of livers, slices were removed for histopathological examination. Microsomes were prepared after homogenization and centrifugation of about 2g liver. In addition, meta- and para-dichlorobenzene were investigated concurrently.
- Positive control:
- Not reported
Results and discussion
- Details on results:
- The acute hepatotoxicity and response of hepatic cytochrome P450 to treatment with o-dichlorobenzene were investigated in male rats that were gavaged with single doses, then evaluated 24 hours later. Centrilobular hepatic necrosis at the minimal level first appeared at 172mg/kg bw, increased to mild at 246 mg/kg bw and remained at that level for all higher dosages. The activities of aspartate aminotransferase and alanine aminotransferase were increased at 172mg/kg bw, and higher o-dichlorobenzene dosages generally reflected a dose-dependent increase in both enzyme activities. Centrilobular vacuolar degeneration first appeared at 98mg/kg bw, with severity increasing to mild soon thereafter. Hepatic cytochrome P450 levels were decreased from control levels by about 20 % at dosages as low as 75mg/kg bw and at the highest dosages (up to 1784 mg/kg bw) the decrease reached more than 50 %.
Any other information on results incl. tables
Investigated parameters exhibited similar patterns demonstrating that ortho-dichlorobenzene was the most toxic in terms of both earliest onset and degree of response at higher dosages.
Applicant's summary and conclusion
- Executive summary:
The acute hepatotoxicity and response of hepatic cytochrome P450 to treatment with the three isomers of dichlorobenzene was investigated. In a study design employing one animal per dose level, F-344 rats were gavaged with up to 25 different dosages (up to 1784mg ortho-dichlorobenzene /kg bw). Preparation and analysis started 24h later after anesthetizing and exsanguination of rats. Hepatic necrosis and vacuolar degeneration were examinated by open light-microscopic histopathological examination of liver slices. Serum alanine aminotransferase and serum aspatate aminotransferase were assayed commercially.
Centrilobular hepatic necrosis at the minimal level first appeared at 172mg/kg bw, increased to mild at 246mg/kg bw and remained at that level for all higher dosages. The activities of aspartate aminotransferase and alanine aminotransferase were increased at 172mg/kg bw, and higher o-dichlorobenzene dosages generally reflected a dose-dependent increase in both enzyme activities. Centrilobular vacuolar degeneration first appeared at 98mg/kg bw, with severity increasing to mild soon thereafter. Hepatic cytochrome P450 levels were decreased from control levels by about 20% at dosages as low as 75mg/kg bw and at the highest dosages (up to 1784mg/kg bw) the decrease reached more than 50%. Ortho-dichlorobenzene produced a dose-dependent decrease in P450 beginning at dosages lower than the onset of necrosis and appeared to be a suicide substante for P450.
Results exhibited similar patterns demonstrating that ortho-dichlorobenzene was the most toxic in terms of both earliest onset and degree of response at higher dosages.
(Allis, J.W. et al., 1992)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.